Phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: A Southwest Oncology Group Study 9617. - Chauncey,T.R.; Rankin,C.; Anderson,J.E.; Chen,I.M.; Kopecky,K.J.; Godwin,J.E.; Kalaycio,M.E.; Moore,D.F.; Shurafa,M.S.; Petersdorf,S.H.; Kraut,E.H.; Leith,C.P.; et al. (Leukemia Res, 2000)